Seven Europe-based drug firms have announced plans to pool their research efforts together with universities and smaller companies in a project which aims to develop tomorrow’s medicines. The European Lead Factory (ELF), backed by the EU, is backed by €196m ($265m). €80m ($107m) is being provided by the European Commission’s Seventh Framework Programme for Research…
The rest of this content is only accessible to Global Venturing Subscribers.
This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.
